Twin Health
Twin Health uses its AI-powered Digital Twin™ technology to help reverse chronic metabolic diseases with personalized health recommendations.
Secondary Market Price
How Twin Health Measures Up
To help you manage your Twin Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Twin Health's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Twin Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Twin Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Twin Health provides a service for managing chronic metabolic diseases such as type 2 diabetes, prediabetes, and obesity. The company combines a technology platform with a clinical care team, offering its metabolic health benefit exclusively through employers and health plans. Its Digital Twin™ technology creates a virtual model of a member's metabolism using data from smart devices, meal logs, and lab work. This model generates personalized, real-time recommendations for nutrition, activity, and sleep, which are delivered through an app. A clinical care team provides guidance to members. Founded in 2018 by Jahangir Mohammed and Terry Poon, the company is headquartered in Mountain View, California, and has an office in Chennai, India. Its approach has been reviewed by organizations including the American Heart Association and the American Diabetes Association.
Looking forward, Twin Health aims to expand its partnerships with employers and health plans. The company has recently been involved in several public activities, including having its CEO present at the Nasdaq opening bell to discuss its technology. A recent study published in NEJM Catalyst reported that in a clinical trial of Twin Health's program, 85% of participants stopped using GLP-1 medications and 71% lowered their A1C levels below 6.5%. The company also hosted a joint event with Peloton Interactive to promote physical activity and metabolic health. In September 2025, Twin Health raised $53 million in a Series E funding round.
- Sequoia Capital
- ICONIQ Growth
- Peak XV Partners
- Perceptive Advisors
- Sofina
- Temasek
- Helena
- Corner Ventures
- LTS Investments
- Maj Invest
- Co-Founder, CEO Jahangir Mohammed
- Co-Founder, EVP, & CTO Terry Poon
- Co-Founder, VP Research Maluk Mohamed
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Twin Health worth joining?
Deciding whether to join a startup like Twin Health depends on your personal career goals and risk tolerance. Tools like Prospect can help you analyze the potential value of your equity compensation to make a more informed financial decision.
What should I do with my Twin Health stock?
Managing private company stock involves complex tax and timing decisions that depend on your personal financial situation. Platforms like Prospect offer personalized strategies for exercising options and selling shares to help you maximize your potential returns.
Can you sell Twin Health stock?
Selling stock in a private company like Twin Health is often possible through events like tender offers or on secondary markets, though it is more restricted than selling public stock. Equity management platforms can help you identify these opportunities and create a tax-optimized selling strategy.
How can I find the value of my Twin Health stock?
Since Twin Health is a private company, its stock value isn't publicly listed, but it can be estimated based on its latest 409A valuation and private market data. You can use a service like Prospect, which uses machine learning models to project your equity's potential value based on various data points.
What is Twin Health's equity worth?
The precise valuation of a private company like Twin Health is not public information and is typically determined during funding rounds. To understand what your specific equity holdings could be worth, you can use tools that model future outcomes based on your grant details and market data.
What is Twin Health's stock ticker symbol?
As a private company, Twin Health is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell Twin Health stock?
Selling private stock is sometimes possible through tender offers, but buying it is generally restricted to accredited investors during specific funding rounds. Tools like Prospect are designed to help employees manage and plan for selling their existing equity, rather than facilitating new purchases.
What is the criteria to buy or invest in Twin Health stock?
Investing in a private startup like Twin Health is typically limited to institutional investors and accredited investors who meet specific financial criteria set by regulators. Employees, on the other hand, usually acquire equity as part of their compensation package rather than through direct investment.
